Announcements
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
- GeneType to Enter Canadian and New Zealand Markets
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
- Genetic Technologies Expands Operational Capacity in North America
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
- GeneType and Humanise Health host “Know Your Risk” Event
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
- Appendix 4C & Quarterly Business Update – March 2024
More ▼
Key statistics
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 4.85m |
Free float | 1.17m |
P/E (TTM) | -- |
Market cap | 4.18m USD |
EPS (TTM) | -1.15 USD |
--
More ▼